Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines

Vaccine

Volumn 32, Issue 28, 2014, Pages 3495-3500

  McElligott, Martha ^a,b   Vickers, Imelda ^a,b   Cafferkey, Mary ^a,b,d   Cunney, Robert ^a,c   Humphreys, Hilary ^b  

^a CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^d PERDANA UNIVERSITY   (Malaysia)

Author keywords

7 13 valent pneumococcal conjugate vaccines; Antimicrobial resistance; Epidemiology; Non vaccine type pneumococci; Serotypes; Streptococcus pneumoniae

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG; 13-VALENT PNEUMOCOCCAL VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONJUNCTIVITIS; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; IMMUNIZATION; IRELAND; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; OTITIS MEDIA; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TEMPORAL ANALYSIS; TREND STUDY; CLASSIFICATION; EPIDEMIOLOGY; HETEROZYGOTE; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIOLOGY; PNEUMOCOCCAL INFECTIONS; SENTINEL SURVEILLANCE; SEROTYPING;

CARRIER STATE; CHILD; DRUG RESISTANCE, BACTERIAL; HOSPITALS, PEDIATRIC; HUMANS; IRELAND; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SENTINEL SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84901420834     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.047     Document Type: Article

References (40)

1. van der Linden M., Winkel N., Kuntzel S., Farkas A., Perniciaro S.R., Reinert R.R., et al. Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany. PLoS ONE 2013, 8:e60848.
2. European Centre for Disease Control Surveillance of Invasive Pneumococcal Disease in Europe 2010, [last accessed December 2013]. http://ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx%3FID=1021.
3. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
4. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006, 25:602-607.
5. Fenoll A., Aguilar L., Vicioso M.D., Gimenez M.J., Robledo O., Granizo J.J. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009. BMC Infect Dis 2011, 11:239.
6. Grall N., Hurmic O., Al Nakib M., Longo M., Poyart C., Ploy M.C., et al. Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine. Eur J Clin Microbiol Infect Dis 2011, 30:1511-1519.
7. Wroe P.C., Lee G.M., Finkelstein J.A., Pelton S.I., Hanage W.P., Lipsitch M., et al. Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J 2012, 3:249-254.
8. Kyaw M.H., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006, 6:1455-1463.
9. Weil-Olivier C., van der Linden M., de Schutter I., Dagan R., Mantovani L. Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective. BMC Infect Dis 2012, 12:207.
10. Routine Childhood Immunisation Schedule, <%3F> [last accessed February 2014]. http://www.immunisation.ie/en/Downloads/NIACGuidelines/PDFFile_17423_en.pdf.
11. Summary Immunisation Uptake Statistics, <%3F> [last accessed February 2014]. http://www.hpsc.ie/hpsc/A-Z/VaccinePreventable/Vaccination/ImmunisationUptakeStatistics/Immunisationuptakestatisticsat12and24monthsofage/File,954,en.pdf.
12. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 2009, 15(Suppl. 3):16-20.
13. Bennett D., Lennon B., Humphreys H., Cafferkey M. Penicillin susceptibility and epidemiological typing of invasive pneumococcal isolates in the Republic of Ireland. J Clin Microbiol 2003, 41:3641-3648.
14. Vickers I., Fitzgerald M., Murchan S., Cotter S., O'Flanagan D., Cafferkey M., et al. Serotype distribution of Streptococcus pneumoniae causing invasive disease in the Republic of Ireland. Epidemiol Infect 2011, 139:783-790.
15. Health Protection Surveillance Centre Epidemiology of invasive Streptococcus pneumoniae infection in Ireland 2011, [last accessed December 2013]. http://www.hpsc.ie/hpsc/A-Z/VaccinePreventable/PneumococcalDisease/Publications/AnnualReportsonInvasivePneumococcalDisease/.
16. Rapola S., Salo E., Kiiski P., Leinonen M., Takala A.K. Comparison of four different sampling methods for detecting pharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children. J Clin Microbiol 1997, 35:1077-1079.
17. Vickers I., O'Flanagan D., Cafferkey M., Humphreys H. Multiplex PCR to determine Streptococcus pneumoniae serotypes causing otitis media in the Republic of Ireland with further characterisation of antimicrobial susceptibilities and genotypes. Eur J Clin Microbiol Infect Dis 2011, 30:447-453.
18. Laufer A.S., Thomas J.C., Figueira M., Gent J.F., Pelton S.I., Pettigrew M.M. Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: implications for the conjugate vaccine. Vaccine 2010, 28:2450-2457.
19. Jin P., Kong F., Xiao M., Oftadeh S., Zhou F., Liu C., et al. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 2009, 200:1375-1380.
20. Jin P., Xiao M., Kong F., Oftadeh S., Zhou F., Liu C., et al. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol 2009, 47(August (8)):2470-2474.
21. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-third information supplement. CLSI document M100-S23 2013, Clinical Laboratory Standards Institute, Wayne, PA.
22. Syrogiannopoulos G.A., Katopodis G.D., Grivea I.N., Beratis N.G. Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old. Clin Infect Dis 2002, 35:1174-1182.
23. Hausdorff W.P., Yothers G., Dagan R., Kilpi T., Pelton S.I., Cohen R., et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002, 21:1008-1016.
24. Marimon J.M., Ercibengoa M., García-Arenzana J.M., Alonso M., Pérez-Trallero E. Streptococcus pneumoniae ocular infections, prominent role of unencapsulated isolates in conjunctivitis. Clin Microbiol Infect 2013, 19:E298-E305.
25. Yao K.H., Wang L.B., Zhao G.M., Zheng Y.J., Deng L., Huang J.F., et al. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine 2011, 29:2296-2301.
26. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., Spratt B.G. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003, 187:1424-1432.
27. Sá-Leão R., Pinto F., Aguiar S., Nunes S., Carriço J.A., Frazão N., et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol 2011, 49:1369-1375.
28. Abdelnour A., Soley C., Guevara S., Porat N., Dagan R., Arguedas A. Streptococcus pneumoniae serotype 3 among Costa Rican children with otitis media: clinical, epidemiological characteristics and antimicrobial resistance patterns. BMC Pediatr 2009, 9:52.
29. Poolman J., Kriz P., Feron C., Di-Paolo E., Henckaerts I., Miseur A., et al. Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics. Vaccine 2009, 27:3213-3222.
30. Fenoll A., Aguilar L., Gimenez M.J., Vicioso M.D., Robledo O., Granizo J.J., et al. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain. Int J Antimicrob Agents 2012, 40:18-23.
31. Grivea I.N., Tsantouli A.G., Michoula A.N., Syrogiannopoulos G.A. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece. Vaccine 2011, 29:8882-8887.
32. Tocheva A.S., Jefferies J.M., Rubery H., Bennett J., Afimeke G., Garland J., et al. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 2011, 29:4400-4404.
33. Harboe Z.B., Thomsen R.W., Riis A., Valentiner-Branth P., Christensen J.J., Lambertsen L., et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009, 6(5):e1000081.
34. Pai R., Moore M.R., Pilishvili T., Gertz R.E., Whitney C.G., Beall B. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis 2005, 192:1988-1995.
35. Gant C.M., Rosingh A.W., López-Hontungas J.L., van der Heijden M., González-Moran F., Bijlsma J.J., et al. Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance. Antimicrob Agents Chemother 2012, 56:4988-4989.
36. Grivea I.N., Sourla A., Ntokou E., Chryssanthopoulou D.C., Tsantouli A.G., Syrogiannopoulos G.A. Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece. BMC Infect Dis 2012, 12:255.
37. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-e11.
38. Richter S.S., Heilmann K.P., Dohrn C.L., Riahi F., Diekema D.J., Doern G.V. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1). Emerg Infect Dis 2013, 19:1074-1083.
39. Sá-Leão R., Nunes S., Brito-Avõ A., Frazão N., Simões A.S., Crisóstomo M.I., et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 2009, 15(11):1002-1007.
40. Surveillance of Antimicrobial Consumption in Europe 2010, http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-antibiotic-consumption-ESAC-report-2010-data.pdf [last accessed February 2014].